Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,736
-$7,602 QoQ
Shares Held
209
-76.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#182
of 198 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. ARVN ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in ARVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,736 | 209 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,338 | 881 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,567 | 891 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $8,537 | 1,002 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,446 | 740 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $7,448 | 1,061 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $28,869 | 1,506 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $41,255 | 1,675 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $52,919 | 1,988 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $94,819 | 2,297 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $95,490 | 2,320 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $12,333 | 628 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $16,281 | 656 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $12,731 | 466 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $10,365 | 303 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,704 | 353 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $24,959 | 593 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $74,904 | 1,113 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,591,626 | 19,377 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,621,986 | 19,737 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,308,384 | 16,992 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $34,371 | 520 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $12,484 | 147 | Shares | Defined | 2021-02-04 | |
| 2020-06-30 | $20,223 | 603 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $57,790 | 1,434 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||